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Sudden cardiac death (SCD) due ventricular tachyarrhythmias is an important cause of 
mortality world wide. While the majority of these deaths occur in those with structural heart 
disease, a small percentage (about 4%) can occur in those with structurally normal heart as well 
[1]. Such primary electrical disorders of the heart which cause SCD are now called as 
channelopathies as they involve the dysfunction (either a gain or a loss of function) of cardiac 
ion   channels.                                                                          
In this issue of the journal, Madhavan SR et al [2] present epidemiological data on SCD in 
South India based on a prospective mortality surveillance conducted in 45 villages with 
180,162 subjects. They noted that SCD contributed to about half of the cardiovascular deaths in 
rural South India. SCD contributed to 17% of the total deaths excluding accidental deaths. 
Hypertension, diabetes mellitus and a history of myocardial infarction / coronary artery disease 
were noted to be the significant associations.                                                 
Sudden cardiac death can be an initial presentation or preceded by symptoms related to 
arrhythmias or hemodynamically significant cardiovascular disorders. Sometimes evaluation is 
called for due to family history of sudden cardiac death. In any case, the evaluation begins with 
a detailed history of clinical details, family history if present and a clinical evaluation to look 
for potential conditions which can cause SCD. This will be followed by the assessment of a 
baseline electrocardiogram and other investigations as deemed necessary. An echocardiogram 
is useful in documenting structural heart diseases prone for SCD like severe aortic stenosis and 
hypertrophic cardiomyopathy. Stress testing for myocardial ischemia or inducible arrhythmia; 
Holter   monitoring,   loop   monitoring   and   implantable   loop   recorders   for   documenting 
siginificant arrhythmia and finally genetic testing in case of suspected inherited arrhythmias 
would be other important investigations to be undertaken in this setting.                                  
Prevention of SCD in heart failure and left ventricular dysfunction assumes great importance as 
this is one of the largest groups in the whole arena of sudden cardiac death. Rather than pump 
failure, sudden cardiac death is the most common mode of death in persons with left ventricular 
dysfunction, more so in those with mild and moderate left ventricular dysfunction. Pump failure 
deaths definitely increase in those with severe left ventricular failure. Implantable defibrillators 
have been shown to be the most important way of prevention of SCD in this subset of patients 
by various large clinical trials like Multicenter Automatic Defibrillator Implantation Trial 
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(MADIT), Multicenter Unsustained Tachycardia Trial (MUSTT), and MADIT-II [3]. Optimal 
treatment of heart failure with medications will also go a long way in reducing the symptoms 
and possibility of sudden cardiac death in this group of patients.                                             
At the community level, measures to improve the coronary risk factors can bring down the 
incidence of coronary artery disease as it is a major contributor to SCD. Another important 
aspect at the community level is the implementation of emergency medical services which can 
provide immediate medical care at the onset of symptoms of diseases which can lead to sudden 
cardiac   death.                                                                                                
Even though implantation of cardioverter-defibrillator is finally the answer in prevention of 
SCD in most inherited arrhythmias, several other interventions have been found useful. These 
include beta blockers in catecholaminergic polymorphic ventricular tachycardia and many 
subtypes of congenital long QT syndromes, quinidine in Brugada syndrome [3] and left cardiac 
sympathetic denervation in congenital long QT syndrome and catecholaminergic polymorphic 
ventricular tachycardia [4]. Interestingly, left cardiac sympathetic denervation has also been 
shown to reduce the incidence of sudden cardiac death among certain subgroups of post 
myocardial infarction patients at high risk for SCD [5].                                                
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